Evidence map›Paper›PMID 31341851›Full record

ArticleIranian journal of public health2019

Target Site Insensitivity Detection in Deltamethrin Resistant

Reza Zeidabadinezhad, Hassan Vatandoost, Mohammad Reza Abai, Navid Dinparast Djadid, Abbasali Raz, Mohammad Mahdi Sedaghat, Mohamad Ali Oshaghi, Ahmad Raeisi, Neda Adibi

Open access · goldAbstract read
PubMed Full text at PMC
In one paragraph

Article in Iranian journal of public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Reza ZeidabadinezhadDepartment of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Hassan VatandoostDepartment of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohammad Reza AbaiDepartment of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Navid Dinparast DjadidMalaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute, Tehran, Iran.
Abbasali RazMalaria and Vector Research Group, Biotechnology Research Center, Pasteur Institute, Tehran, Iran.
Mohammad Mahdi SedaghatDepartment of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Mohamad Ali OshaghiDepartment of Medical Entomology and Vector Control, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Ahmad RaeisiMalaria Control Unit, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Neda AdibiMalaria Control Unit, Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran.
Tehran University of Medical Sciences · IRMinistry of Health and Medical Education · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome mosquito species which belong to the

methodsSpecimens of

resultsOur results revealed high levels of resistance to deltamethrin 0.05%. The lethal times i.e. LT

conclusionThis finding will provide a clue for management of insecticide resistance in mosquito which are vectors of arboviruses and decision for replacement of novel approach for vector control.

Indexed as

Culex pipiensDeltamethrinKnockdown resistance

Identifiers

PMID31341851
PMCPMC6635334
OpenAlexW2954586918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.